Performance measurement for co-occurring mental health and substance use disorders.
BACKGROUND
Co-occurring mental health and substance use disorders (COD) are the norm rather than the exception. It is therefore critical that performance measures are developed to assess the quality of care for individuals with COD irrespective of whether they seek care in mental health systems or substance abuse systems or both.


METHODS
We convened an expert panel and asked them to rate a series of structure, process, and outcomes measures for COD using a structured evaluation tool with domains for importance, usefulness, validity, and practicality.


RESULTS
We chose twelve measures that demonstrated promise for future pilot testing and refinement. The criteria that we applied to select these measures included: balance across structure, process, and outcome measures, quantitative ratings from the panelists, narrative comments from the panelists, and evidence the measure had been tested in a similar form elsewhere.


CONCLUSIONS
To be successful performance measures need to be developed in such a way that they align with needs of administrators and providers. Policymakers need to work with all stakeholders to establish a concrete agenda for developing, piloting and implementing performance measures that include COD. Future research could begin to consider strategies that increase our ability to use administrative coding in mental health and substance use disorder systems to efficiently capture quality relevant clinical data.
Dausey
David J
DJ
Carnegie Mellon University, Pittsburgh PA 15213, USA. dausey@rand.org
Pincus
Harold A
HA
Herrell
James M
JM
D006801:Humans; D001523:Mental Disorders / Q000150:complications*; D010043:Outcome and Process Assessment, Health Care / Q000458:organization & administration*; D019984:Quality Indicators, Health Care / Q000458:organization & administration* / Q000592:standards; D011787:Quality of Health Care / Q000458:organization & administration; D015203:Reproducibility of Results; D019966:Substance-Related Disorders / Q000150:complications*